Pfizer (LTS:0Q1N) Marketable Securities

: $9,837 Mil (As of Dec. 2023)

View and export this data going back to 1967. Start your Free Trial

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Pfizer's Marketable Securities for the quarter that ended in Dec. 2023 was $9,837 Mil.

Pfizer's annual Marketable Securities declined from Dec. 2021 ($29,125 Mil) to Dec. 2022 ($22,316 Mil) and declined from Dec. 2022 ($22,316 Mil) to Dec. 2023 ($9,837 Mil).

Pfizer Marketable Securities Historical Data

The historical data trend for Pfizer's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

8,525.00

10,437.00

29,125.00

22,316.00

9,837.00

Pfizer Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															22,316.00	17,806.00	42,153.00	41,033.00	9,837.00

Pfizer Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Pfizer (LTS:0Q1N) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Pfizer Marketable Securities Related Terms

Thank you for viewing the detailed overview of Pfizer's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (LTS:0Q1N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (LTS:0Q1N) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (LTS:0Q1N) Headlines

No Headlines